Orexigen Therapeutic (OREX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OREX | AMGN | VRTX | BMY | GILD |
| Company | Orexigen Therapeutic | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 0.25 | 279.38 | 465.19 | 56.18 | 88.39 |
| High | 0.32 | 281.36 | 465.51 | 56.77 | 89.04 |
| Low | 0.22 | 276.70 | 458.05 | 55.84 | 87.63 |
| Last | 0.22 | 277.06 | 464.31 | 56.26 | 88.29 |
| Change | -0.12 | -4.30 | -1.39 | +0.04 | -0.11 |
| % Change | -34.41% | -1.53% | -0.30% | +0.07% | -0.12% |
| Volume | 3,735,400 | 483,508 | 135,537 | 1,029,897 | 1,840,039 |
| 20-Day Average Volume | 2,308,280 | 2,451,826 | 1,166,050 | 11,309,476 | 7,176,995 |
| Previous Close | 0.34 | 281.36 | 465.70 | 56.22 | 88.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.47 | 312.03 | 482.34 | 55.14 | 90.77 |
| 20-Day Raw Stochastic | 4.24% | 2.30% | 6.13% | 52.32% | 17.82% |
| 20-Day Relative Strength | 32.36% | 26.73% | 43.62% | 57.59% | 49.53% |
| Weighted Alpha | -72.99 | -3.59 | +22.30 | +21.40 | +22.61 |
| Today's Opinion | N/A | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Previous Opinion | N/A | 40% Sell | 16% Buy | 100% Buy | 80% Buy |
| Last Month's Opinion | N/A | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +17.37% since 03/27/18 | -13.46% since 11/11/24 | -7.94% since 11/11/24 | -5.28% since 11/11/24 | -9.34% since 11/11/24 |
| Low | 0.17 on 03/28/18 | 277.32 on 11/18/24 | 458.10 on 11/15/24 | 55.82 on 11/15/24 | 87.74 on 11/18/24 |
| High | 0.39 on 04/02/18 | 321.22 on 11/12/24 | 508.04 on 11/12/24 | 60.62 on 11/12/24 | 96.84 on 11/12/24 |
| 1-Month | |||||
| %Chg | -81.57% since 03/02/18 | -13.42% since 10/18/24 | -4.37% since 10/18/24 | +6.46% since 10/18/24 | +1.44% since 10/18/24 |
| Low | 0.17 on 03/27/18 | 277.32 on 11/18/24 | 458.10 on 11/15/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 1.42 on 03/09/18 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -82.02% since 01/03/18 | -13.36% since 08/16/24 | -3.24% since 08/16/24 | +14.79% since 08/16/24 | +19.23% since 08/16/24 |
| Low | 0.17 on 03/27/18 | 277.32 on 11/18/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 73.27 on 08/19/24 |
| High | 1.60 on 02/22/18 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -89.17% since 10/03/17 | -10.87% since 05/17/24 | +3.75% since 05/17/24 | +28.68% since 05/17/24 | +29.90% since 05/17/24 |
| Low | 0.17 on 03/27/18 | 277.32 on 11/18/24 | 435.57 on 05/30/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 2.32 on 10/13/17 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,212 | 152,449,728 | 119,931,248 | 114,024,112 | 110,169,920 |
| Shares Outstanding, K | 18,890 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 33,710,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -24,520,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 18,900,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -20,830,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 2.46 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.35 on 11/13/17 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 05/08/18 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.40 | 0.00 | 50.00 | 20.79 |